![]()
|
|
|
Agios, iNovacia announce new collaboration
March 2012
SHARING OPTIONS:
STOCKHOLM, Sweden—iNovacia AB has announced a
high-throughput screening collaboration with Cambridge, Mass.-based Agios
Pharmaceuticals, a company focusing on cancer metabolism. Per the terms of the
agreement, iNovacia will provide small-molecule lead generation services for
the collaboration in addition to identifying modulators of pharmaceutical
targets of interest to Agios through use of iNovacia’s proprietary screening
library. Financial details for the collaboration were not disclosed.
“We have had successful screening projects with Agios in the
past and we are now proud to be able to extend this relationship,” Dr. Thomas
Olin, CEO of iNovacia, said in a press release. “We are pleased that Agios and
other U.S. and European companies continue to appreciate the value of our
premium screening operations and proprietary screening library as a means to
generate high-quality chemistry starting points.” Back |
|
||
|
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|